Navigation Links
Warner Chilcott Announces Secondary Equity Offering
Date:11/13/2009

rtainties. The following represent some, but not necessarily all, of the factors that could cause actual results to differ from historical results or those anticipated or predicted by our forward-looking statements: our substantial indebtedness; competitive factors in the industry in which we operate (including the approval and introduction of generic or branded products that compete with our products); our ability to protect our intellectual property; a delay in qualifying our manufacturing facility to produce our products or production or regulatory problems with either third party manufacturers upon whom we may rely for some of our products or our own manufacturing facilities; pricing pressures from reimbursement policies of private managed care organizations and other third party payors, government sponsored health systems, the continued consolidation of the distribution network through which we sell our products, including wholesale drug distributors and the growth of large retail drug store chains; the loss of key senior management or scientific staff; adverse outcomes in our outstanding litigation or an increase in the number of litigation matters to which we are subject; government regulation affecting the development, manufacture, marketing and sale of pharmaceutical products, including our ability and the ability of companies with whom we do business to obtain necessary regulatory approvals; our ability to manage the growth of our business by successfully identifying, developing, acquiring or licensing new products at favorable prices and marketing such new products; our ability to obtain regulatory approval and customer acceptance of new products, and continued customer acceptance of our existing products; changes in tax laws or interpretations that could increase our consolidated tax liabilities; the other risks identified in our periodic filings including our Annual Report on Form 10-K for the year ended December 31, 2008, as amended, and our Current Re
'/>"/>
SOURCE Warner Chilcott plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Warner Chilcott Completes Acquisition of P&Gs Global Branded Prescription Pharmaceuticals Business
2. Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development
3. Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent
4. Tianyin Pharmaceutical co., Inc. Announces Record First Quarter 2010 Financial Results
5. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
6. Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results
7. Misonix Announces New Distribution Agreement for Saudi Arabia and Other Middle Eastern Countries
8. Milestone Scientific Announces Third Quarter 2009 Results
9. EF Johnson Technologies Announces Third Quarter Results
10. Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology
11. LifeVantage Announces Unaudited First Quarter Fiscal 2010 Financial and Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... BOSTON , Oct. 1, 2014   ... market-leading provider of Anesthesia Information Management Systems (AIMS), ... Systems, LLC , a wholly owned subsidiary of ... healthcare information systems and connectivity solutions.  ... http://photos.prnewswire.com/prnh/20140930/149407 This partnership ...
(Date:10/1/2014)... NeuroCall, Inc., ("NeuroCall") announced today that it ... Teleneurology services. Dr. Ricardo Garcia-Rivera , Founder and ... proud that our quality of service has been recognized ... lifesaving support and continuity of care to patients of ... the United States ." NeuroCall ...
(Date:10/1/2014)... , Oct. 1, 2014 Quantum ... scaling volume production of photoactive quantum dots for ... . While offering numerous advantages for solar power ... large quantities of quantum dots with which to ... kept them from commercial utilization and acceptance. The ...
Breaking Medicine Technology:Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 2Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 3NeuroCall Awarded Joint Commission Accreditation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 3
... 2011 Smith & Nephew Orthopaedics (NYSE: ... agreement with French biotechnology company Graftys. The deal gives ... calcium phosphate bone void filler in the U.S., and ... "We are committed to offering our surgeon customers innovative ...
... (OTC: HEWA) a leading VIPPS accredited retail mail-order pharmacy, ... ended March 31, 2011. In the ... increased $1,031,003 to $2,284,552, up 82% compared to the ... strength in its prescription business and the acquisition of ...
Cached Medicine Technology:Smith & Nephew Signs Distribution Agreement for Unique Injectable Bone Void Filler With Graftys 2Smith & Nephew Signs Distribution Agreement for Unique Injectable Bone Void Filler With Graftys 3HealthWarehouse.com Reports 82% Quarter-Over-Quarter Revenue Growth in the First Quarter 2011 2
(Date:10/1/2014)... 2014 Anti Aging Clinic (AntiAgingClinic.ca), the ... destination of choice, is announcing a discounted cost on ... December. , “We’re doing this because we want to ... top skin clinic in Toronto,” says Dr. Brian Sieber, ... at Anti Aging Clinic, including laser facials, genesis laser ...
(Date:10/1/2014)... in Bahir Dar, Ethiopia, at the occasion of ... gathered some 150 African and international leishmaniasis experts, ... safety and efficacy monitoring plan, carried out ... Sudan, Uganda, and Ethiopia, were presented to key ... to treatment of kala-azar with the combination of ...
(Date:10/1/2014)... October 01, 2014 Woodland Hills ... to a group of dental specialists who treat full ... Spain city of Oviedo. Dr. Reshad of the Anacapa ... with clients on two continents, will give a full-day ... full mouth reconstruction. , “These specialists want to improve ...
(Date:10/1/2014)... WA (PRWEB) October 01, 2014 Two ... will take them across the country in an effort ... today’s military families. The cyclists, a father-daughter team, ... states, beginning in Blaine, Washington and finishing in Key ... benefit Hope For The Warriors®, a national nonprofit organization ...
(Date:10/1/2014)... 2014 UP4 Probiotics will be donating ... to The National Network to End Domestic Violence ( ... was chosen through nationwide polling that took place during ... outlets. , “We are proud to have been ... every sale of UP4 Women’s Probiotics during the month ...
Breaking Medicine News(10 mins):Health News:Anti Aging Clinic, the GTA’s Premier Provider of Anti Aging Treatments, Announces Deal on Units of Botox 2Health News:Results of large-scale roll out of combination treatment for kala-azar in Eastern Africa 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 2Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 3Health News:Woodland Hills Dental Implants Expert Training Dental Specialists in Spain Later This Week 4Health News:Father-Daughter Cycling Duo to Ride Cross-Country to Benefit Hope For The Warriors 2Health News:UP4 Probiotics Partners with The National Network to End Domestic Violence 2
... , , , ... David Letterman joined Ronald O. Perelman, chairman of MacAndrews & ... Herbert Pardes at a ceremony today officially opening the new ... Center, an innovative center offering comprehensive, world-class cardiovascular care and ...
... , SCHAUMBURG, Ill., Sept. 14 More than ... Yet when detected early, skin cancer has a cure rate of 99 ... of Dermatology,s National Melanoma/Skin Cancer Screening Program conducted free skin cancer screenings ... , "With its emphasis on agriculture, the fair provided ...
... ... at Leading IP Communications Conference in Los Angeles , ... Tigard, Ore. (Vocus) September 14, 2009 -- FaxBack®, a leading provider ... its VoIP Plug-In for Microsoft Fax received a "Best of Show Award" in the SMB ...
... , , , ... announced today the results of its Phase 2b Dextofisopam clinical trial ... syndrome. , , Although the primary efficacy ... symptoms) did not reach statistical significance, the percentage responding for the ...
... Advocates to Meet with 40 Key Congressional Committee ... WASHINGTON, Sept. 14 This week, the Coalition for Pulmonary ... Week. The official dates are September 14-21. In the more ... staffers, the CPF will be advocating for passage of the Pulmonary Fibrosis ...
... Inc. (OTC BB: ALRX). Speaking at the 11th Annual ... City, AlphaRx Director Dr. David Milroy presented a company ... delivery platform and the significant developments anticipated within the ... products in different stages of clinical development by the ...
Cached Medicine News:Health News:Ronald O. Perelman Heart Institute of NewYork-Presbyterian Hospital/Weill Cornell Medical Center Opens as a Center for Innovative, World-Class Cardiac Care and Patient Education 2Health News:Ronald O. Perelman Heart Institute of NewYork-Presbyterian Hospital/Weill Cornell Medical Center Opens as a Center for Innovative, World-Class Cardiac Care and Patient Education 3Health News:Ronald O. Perelman Heart Institute of NewYork-Presbyterian Hospital/Weill Cornell Medical Center Opens as a Center for Innovative, World-Class Cardiac Care and Patient Education 4Health News:Ronald O. Perelman Heart Institute of NewYork-Presbyterian Hospital/Weill Cornell Medical Center Opens as a Center for Innovative, World-Class Cardiac Care and Patient Education 5Health News:Dermatologists Screen More Than 1,300 People for Skin Cancer at Kentucky State Fair 2Health News:Dermatologists Screen More Than 1,300 People for Skin Cancer at Kentucky State Fair 3Health News:FaxBack Awarded "Best of Show" at ITEXPO West 2009 2Health News:FaxBack Awarded "Best of Show" at ITEXPO West 2009 3Health News:Pharmos Announces Results of Phase 2b Irritable Bowel Syndrome Study 2Health News:Pharmos Announces Results of Phase 2b Irritable Bowel Syndrome Study 3Health News:CPF Holds Seventh Annual National Pulmonary Fibrosis Awareness Week 2Health News:CPF Holds Seventh Annual National Pulmonary Fibrosis Awareness Week 3Health News:CPF Holds Seventh Annual National Pulmonary Fibrosis Awareness Week 4Health News:AlphaRx Presents Company Overview and New Product Candidates at the Rodman Renshaw Healthcare Conference 2
... LH 755 simplifies and automates ... expert automation and advanced technologies ... reliable, accurate results every time. ... slide quality with its slide-on-slide ...
Kinetic and endpoint methods for the quantitative determination of creatinine in serum....
For the quantitative determination of creatine kinase-MB in serum. Kinetic Reaction measured at 340 nm. Linearity: 700 IU/L at 37C....
Intended for the quantitative determination of magnesium in serum. Wavelength: 340 nm. Linearity: 9.7 mg/dL (4 mmol/L). Two vials, dry powder reagents....
Medicine Products: